Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells

doi:10.1084/jem.174.4.945

This Article

	Full Text (PDF, 352K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Adorini, L.
	Articles by Fuchs, S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Adorini, L.
	Articles by Fuchs, S.


Social Bookmarking

	What's this?

ARTICLES

Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells

L Adorini, J Moreno, F Momburg, GJ Hammerling, JC Guery, A Valli and S Fuchs
Preclinical Research, Sandoz Pharma Ltd., Basel, Switzerland.

Antigen-presenting cells (APC) transfected with a construct encoding the hen egg-white lysozyme (HEL) amino acid sequence 1-80 constitutively present HEL peptides complexed to major histocompatibility complex (MHC) class II molecules to specific T cell hybridomas, indicating that endogenous cellular antigens can be efficiently presented to class II-restricted T cells. Here we show that exogenous peptide competitors added to HEL-transfected APC can inhibit the presentation of endogenous HEL peptides to class II-restricted T cells. The inhibition is specific for the class II molecule binding the competitor peptide, and it affects to the same extent presentation of exogenous or endogenous HEL peptides. These results, demonstrating that an exogenous competitor can inhibit class II-restricted T cell activation induced by endogenous as well as exogenous antigen, suggest lack of strict compartmentalization between endogenous and exogenous pathways of antigen presentation. Since autoreactive T cells may recognize endogenous, as well as exogenous antigens, the results have implications for the treatment of autoimmune diseases by MHC blockade.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Dissanayake, S. K., Tuera, N., Ostrand-Rosenberg, S. (2005). Presentation of Endogenously Synthesized MHC Class II-Restricted Epitopes by MHC Class II Cancer Vaccines Is Independent of Transporter Associated with Ag Processing and the Proteasome. J. Immunol. 174: 1811-1819 [Abstract] [Full Text]
Nolan, K. F., Strong, V., Soler, D., Fairchild, P. J., Cobbold, S. P., Croxton, R., Gonzalo, J.-A., Rubio, A., Wells, M., Waldmann, H. (2004). IL-10-Conditioned Dendritic Cells, Decommissioned for Recruitment of Adaptive Immunity, Elicit Innate Inflammatory Gene Products in Response to Danger Signals. J. Immunol. 172: 2201-2209 [Abstract] [Full Text]
Rodriguez, F., Harkins, S., Redwine, J. M., de Pereda, J. M., Whitton, J. L. (2001). CD4+ T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal Targeting. J. Virol. 75: 10421-10430 [Abstract] [Full Text]
Qi, L., Ostrand-Rosenberg, S. (2001). H2-O Inhibits Presentation of Bacterial Superantigens, but Not Endogenous Self Antigens. J. Immunol. 167: 1371-1378 [Abstract] [Full Text]
Qi, L., Rojas, J.-M., Ostrand-Rosenberg, S. (2000). Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo. J. Immunol. 165: 5451-5461 [Abstract] [Full Text]
Aiello, S., Noris, M., Piccinini, G., Tomasoni, S., Casiraghi, F., Bonazzola, S., Mister, M., Sayegh, M. H., Remuzzi, G. (2000). Thymic Dendritic Cells Express Inducible Nitric Oxide Synthase and Generate Nitric Oxide in Response to Self- and Alloantigens. J. Immunol. 164: 4649-4658 [Abstract] [Full Text]
Accapezzato, D., Nisini, R., Paroli, M., Bruno, G., Bonino, F., Houghton, M., Barnaba, V. (1998). Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis {delta} Antigen. J. Immunol. 160: 5262-5266 [Abstract] [Full Text]
Badou, A., Savignac, M., Moreau, M., Leclerc, C., Pasquier, R., Druet, P., Pelletier, L. (1997). HgCl2-induced Interleukin-4 Gene Expression in T Cells Involves a Protein Kinase C-dependent Calcium Influx through L-type Calcium Channels. J. Biol. Chem. 272: 32411-32418 [Abstract] [Full Text]
Woulfe, S. L., Bono, C. P., Zacheis, M. L., Welply, J. K., Kirschmann, D. A., Baudino, T. A., Wang, Y., Stone, D. A., Hanson, G. J., Vuletich, J. L., Bedell, L. J., Schwartz, B. D., Howard, S. C. (1997). A Peptidomimetic that Specifically Inhibits Human Leukocyte Antigen DRB1*0401-restricted T Cell Proliferation. J. Pharmacol. Exp. Ther. 281: 663-669 [Abstract] [Full Text]